India, May 21 -- Nanobiotix S.A. (NBTX), a late-stage biotechnology company, on Thursday announced pricing of a follow-on global offering consisting of a public offering and an offering exclusively for qualified investors in Europe.
The public offering consists of 225,373 American Depositary Shares (ADSs), each representing 0.03 nominal value per share of the company's ordinary shares at an offering price of $39.98 per share.
The offering to European investors consists of 1,959,289 ordinary shares and 345,099 pre-funded warrants to subscribe for one ordinary share each at a subscription price of €35.60. The pre-funded warrants will remain exercisable till May 26, 2036.
The aggregate gross proceeds from the global offering are estim...